Immunochemical faecal occult blood tests in primary care and the risk of delay in the diagnosis of colorectal cancer

References

• GLOBOCAN 2008. Available at: http://globocan.iarc.fr (accessed 8 February 2013).
   Google Scholar
• Cancer incidence in Sweden 2011. National Board of Health and Welfare Available at: http://www.socialstyrelsen.se (accessed 8 February 2013).
   Google Scholar
• Toll AD, Fabius D, Hyslop T, Pequignot E, DiMarino AJ, Infantolino A, et al. Prognostic significance of high-grade dysplasia in colorectal adenomas. Colorectal Dis 2010;13: 370–3.
   Web of Science ®Google Scholar
• Mansson J, Bjorkelund C, Hultborn R. Symptom pattern and diagnostic work-up of malignancy at first symptom presentation as related to level of care: A retrospective study from the primary health care centre area of Kungsbacka, Sweden. Neoplasma 1999;46:93–9.
   PubMed Web of Science ®Google Scholar
• Carlsson L, Hakansson A, Nordenskjold B. Common cancer-related symptoms among GP patients: Opportunistic screening in primary health care. Scand J Prim Health Care 2001;19:199–203.
   PubMed Web of Science ®Google Scholar
• Vandvik PO, Kristensen P, Aabakken L, Farup PG. Abdominal complaints in general practice: Diagnoses and characteristics of patients. Scand J Prim Health Care 2004;22:157–62.
   PubMed Web of Science ®Google Scholar
• Svendsen RP, Stovring H, Hansen BL, Kragstrup J, Sondergaard J, Jarbol DE. Prevalence of cancer alarm symptoms: A population-based cross-sectional study. Scand J Prim Health Care 2010;28:132–7.
   PubMed Web of Science ®Google Scholar
• Astin M, Griffin T, Neal RD, Rose P, Hamilton W. The diagnostic value of symptoms for colorectal cancer in primary care: A systematic review. Br J Gen Pract 2011;61:e231–43.
   PubMed Web of Science ®Google Scholar
• Thompson MR, Perera R, Senapati A, Dodds S. Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg 2007;94:1260–5.
   PubMed Web of Science ®Google Scholar
• Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365–71.
   PubMed Web of Science ®Google Scholar
• Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472–7.
   PubMed Web of Science ®Google Scholar
• Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71.
   PubMed Web of Science ®Google Scholar
• Zorzi M, Fedato C, Grazzini G, Stocco FC, Banovich F, Bortoli A, et al. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy. Gut 2011;60:944–9.
   PubMed Web of Science ®Google Scholar
• Zhu MM, Xu XT, Nie F, Tong JL, Xiao SD, Ran ZH. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta-analysis. J Dig Dis 2010;11:148–60.
   PubMed Web of Science ®Google Scholar
• Rozen P, Comaneshter D, Levi Z, Hazazi R, Vilkin A, Maoz E, et al. Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use. Cancer 2010;116:2115–25.
   PubMed Web of Science ®Google Scholar
• European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Luxembourg: Publications Office of the European Union; 2011. Available at: http://bookshop.europa.eu.
   Google Scholar
• Jellema P, van der Windt DAWM, Bruinvels DJ, Mallen CD, van Weyenberg SJB, Mulder CJ, et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: Systematic review and meta-analysis. BMJ 2010;340: c1269–c.
   PubMed Web of Science ®Google Scholar
• Gillberg A, Ericsson E, Granstrom F, Olsson LI. A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer. Colorectal Dis 2012;14:e539–46.
   PubMed Web of Science ®Google Scholar
• Högberg C, Asplund R. Många feces-Hb-test till liten nytta. Immunkemisk metod ger dålig diagnoshjälp, visar primärvårdsstudie (Small benefit of many feces-Hb tests. Low diagnostic value of the immunochemical method according to a primary health care study). English summary. Lakartidningen 2010;107:1372–5.
   PubMedGoogle Scholar
• Regionalt cancercentrum norr. Available at: http://www. cancercentrum.se/norr/.
   Google Scholar
• Obtained from Oy Medix Biochemica Ab. Available at: http://www.medixbiochemica.com.
   Google Scholar
• NICE clinical guidelines. Referral guidelines for suspected cancer. Available at: http://publications.nice.org.uk (accessed 8 February 2013).
   Google Scholar
• McDonald PJ, Digby J, Innes C, Strachan JA, Carey FA, Steele RJ, et al. Low faecal haemoglobin concentration potentially rules out significant colorectal disease. Colorectal Dis 2013;15:e151–9.
   PubMed Web of Science ®Google Scholar
• Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsene D, Boutreux S, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007;56:210–14.
   PubMed Web of Science ®Google Scholar
• Trickett JP, Donaldson DR, Bearn PE, Scott HJ, Hassall AC. A study on the routes of referral for patients with colorectal cancer and its effect on the time to surgery and pathological stage. Colorectal Dis 2004;6:428–31.
   PubMedGoogle Scholar
• Barrett J, Jiwa M, Rose P, Hamilton W. Pathways to the diagnosis of colorectal cancer: An observational study in three UK cities. Fam Pract 2006;23:15–9.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol 2009;48:27–33.
   PubMed Web of Science ®Google Scholar